These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 19602422

  • 1. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
    Trevitt J, Kawa K, Jalali A, Larsen C.
    Pharmacol Biochem Behav; 2009 Nov; 94(1):24-9. PubMed ID: 19602422
    [Abstract] [Full Text] [Related]

  • 2. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
    Betz AJ, Vontell R, Valenta J, Worden L, Sink KS, Font L, Correa M, Sager TN, Salamone JD.
    Neuroscience; 2009 Sep 29; 163(1):97-108. PubMed ID: 19467297
    [Abstract] [Full Text] [Related]

  • 3. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Exp Neurol; 2004 Sep 29; 189(1):182-8. PubMed ID: 15296848
    [Abstract] [Full Text] [Related]

  • 4. Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements.
    Johnson JA, Montgomery AP, Starr ER, Ludwig J, Trevitt J.
    Eur J Pharmacol; 2018 Aug 15; 833():364-369. PubMed ID: 29883670
    [Abstract] [Full Text] [Related]

  • 5. Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    J Neurol Sci; 2006 Oct 25; 248(1-2):48-52. PubMed ID: 16780890
    [Abstract] [Full Text] [Related]

  • 6. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S.
    J Neurochem; 2004 Nov 25; 91(4):873-80. PubMed ID: 15525341
    [Abstract] [Full Text] [Related]

  • 7. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2013 Oct 10; 250():507-19. PubMed ID: 23867769
    [Abstract] [Full Text] [Related]

  • 8. Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
    Trevitt J, Vallance C, Harris A, Goode T.
    Pharmacol Biochem Behav; 2009 May 10; 92(3):521-7. PubMed ID: 19463269
    [Abstract] [Full Text] [Related]

  • 9. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
    Collins LE, Galtieri DJ, Brennum LT, Sager TN, Hockemeyer J, Müller CE, Hinman JR, Chrobak JJ, Salamone JD.
    Pharmacol Biochem Behav; 2010 Feb 10; 94(4):561-9. PubMed ID: 19958787
    [Abstract] [Full Text] [Related]

  • 10. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.
    Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD.
    Pharmacol Biochem Behav; 2012 Jan 10; 100(3):498-505. PubMed ID: 22037410
    [Abstract] [Full Text] [Related]

  • 11. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
    Ishiwari K, Betz A, Weber S, Felsted J, Salamone JD.
    Pharmacol Biochem Behav; 2005 Feb 10; 80(2):351-62. PubMed ID: 15680188
    [Abstract] [Full Text] [Related]

  • 12. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
    Carlson BB, Wisniecki A, Salamone JD.
    Psychopharmacology (Berl); 2003 Jan 10; 165(3):229-37. PubMed ID: 12420151
    [Abstract] [Full Text] [Related]

  • 13. Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures.
    Kosmowska B, Ossowska K, Wardas J.
    Behav Brain Res; 2022 Jan 24; 417():113585. PubMed ID: 34536428
    [Abstract] [Full Text] [Related]

  • 14. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
    Salamone JD, Carlson BB, Rios C, Lentini E, Correa M, Wisniecki A, Betz A.
    Behav Brain Res; 2005 Jan 30; 156(2):173-9. PubMed ID: 15582103
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
    Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):94-102. PubMed ID: 17445798
    [Abstract] [Full Text] [Related]

  • 16. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
    Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD.
    Pharmacol Biochem Behav; 2011 Sep 02; 99(3):414-22. PubMed ID: 21640750
    [Abstract] [Full Text] [Related]

  • 17. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
    Podurgiel S, Collins-Praino LE, Yohn S, Randall PA, Roach A, Lobianco C, Salamone JD.
    Pharmacol Biochem Behav; 2013 Apr 02; 105():105-11. PubMed ID: 23360954
    [Abstract] [Full Text] [Related]

  • 18. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect.
    Miwa H, Kubo T, Suzuki A, Kondo T.
    Parkinsonism Relat Disord; 2009 Jan 02; 15(1):30-5. PubMed ID: 18693129
    [Abstract] [Full Text] [Related]

  • 19. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
    Tanganelli S, Sandager Nielsen K, Ferraro L, Antonelli T, Kehr J, Franco R, Ferré S, Agnati LF, Fuxe K, Scheel-Krüger J.
    Parkinsonism Relat Disord; 2004 Jul 02; 10(5):273-80. PubMed ID: 15196505
    [Abstract] [Full Text] [Related]

  • 20. Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats.
    Bové J, Marin C, Bonastre M, Tolosa E.
    Synapse; 2002 Dec 15; 46(4):251-7. PubMed ID: 12373740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.